SnagRx vs Willow: Compounded GLP-1 Pricing vs Structured Support
SnagRx vs Willow compares a low-cost compounded GLP-1 option to a structured oral-GLP1 program with follow-up. Early verdict: choose SnagRx if you prioritize predictable, low monthly pricing for compounded semaglutide; choose Willow if you need a structured program with progress tracking and follow-up.
Direct comparison: pricing, medication type, and program focus
This comparison uses only supplied facts. SnagRx advertises compounded semaglutide from $69/month on the 12-month plan and compounded tirzepatide from $119/month, with the rate locked flat at every dose for the life of treatment. Willow positions an oral GLP-1 program and lists a starting price of $299. The two services therefore diverge on price point, medication form, and program emphasis.
Get SnagRx compounded GLP-1 details
Comparison table at a glance
| Criteria | SnagRx | Willow |
|---|---|---|
| Starting price | From $69/month semaglutide (12-month plan); month-to-month $99 | $299 (captured starting price) |
| Medication form | Compounded semaglutide and compounded tirzepatide only; not branded products | Oral GLP-1 program (medication-specific approval status must be confirmed) |
| Pricing model | 12-month plan locks price flat at every dose; month-to-month is more expensive | Higher monthly entry pricing noted for some plans |
| Clinician network and eligibility | OpenLoop Health clinician network; clinician review typically within 5 hours; covers 48 states | Licensed telehealth team; treatment available only when a licensed clinician determines medically appropriate |
| Shipping and fulfillment | Named US 503A partner pharmacies; next-day UPS/FedEx temperature-controlled shipping | Not verified on captured page |
| Support and program features | No coaching or nutrition programming captured; no monthly membership; cancel anytime | Progress tracking tools and follow-up consultations; structured digital workflow emphasized |
Pricing and commitment: who pays less and what you lock in
SnagRx advertises the market-low annual plan pricing: semaglutide from $69/month and tirzepatide from $119/month on a 12-month plan, with the rate locked flat at every dose and at renewal. The site states month-to-month rates are $99 and $149 respectively. Willow’s captured starting price is $299; additional pricing details were not captured. The SnagRx 12-month rate explicitly requires a 12-month commitment to obtain the $69 and $119 figures.
Explore Willow program pricing
Medication form, regulatory notes, and clinician review
SnagRx supplies compounded semaglutide and compounded tirzepatide. The source repeatedly notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. SnagRx names four US 503A partner pharmacies and uses OpenLoop Health clinicians; OpenLoop clinicians retain prescribing decisions and cover 48 states. Willow offers an oral GLP-1 program delivered via a licensed telehealth team; the captured material states treatment is available only when a licensed clinician determines it is medically appropriate. The captured Willow page notes that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable.
Program support and logistics: shipping, follow-up, and tracking
SnagRx advertises next-day UPS or FedEx shipping in temperature-controlled packaging and a clinician review typically within five hours; a declined prescription is refunded in full. SnagRx states no monthly membership, cancel anytime, and includes injection supplies and shipping in the price. Willow emphasizes progress tracking tools, follow-up consultations, and a structured digital workflow to convert medication into sustainable outcomes. The captured Willow evidence did not verify shipping or membership terms.
Distinctive differences summarized
- Price and commitment: SnagRx offers lower annual-plan pricing with a price-lock for titration; Willow lists a higher starting price and was described as higher monthly pricing for some plans.
- Medication form: SnagRx delivers compounded injectable GLP-1s; Willow promotes an oral GLP-1 program.
- Program structure: SnagRx does not advertise coaching or nutrition programming; Willow focuses on progress tracking and follow-up support.
- Clinician and fulfillment details: SnagRx names its clinician network and partner pharmacies and states next-day shipping; Willow emphasizes licensed telehealth but captured shipping details are not available.
Regulatory and safety note
Both sources include the captured regulatory language: compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. SnagRx explicitly advises prospective users to speak with their provider about risks and states its clinicians determine eligibility; Willow states treatment is provided only when a licensed clinician deems it medically appropriate.
Conclusion: Choose based on price or program support
SnagRx vs Willow splits along clear lines. Choose SnagRx if you want compounded semaglutide from $69/month on a 12-month plan with price locked at every dose, named US 503A partner pharmacies, and next-day shipping. Choose Willow if you prioritize an oral GLP-1 program with progress tracking and follow-up consultations delivered via a licensed telehealth team.